Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEX Biometrics ASA Share Issue/Capital Change 2021

Sep 1, 2021

3633_rns_2021-09-01_a2bb44f1-18dc-4290-8660-e2637712f9ec.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

IDEX Biometrics: Employee Share Purchase Plan Share Issue - 1 September 2021

IDEX Biometrics: Employee Share Purchase Plan Share Issue - 1 September 2021

The board of directors of IDEX Biometrics ASA has resolved to issue 913,198

ordinary shares at NOK 2.10 per share to employees who participate in the

company's 2020 Employee Share Purchase Plan (2020 ESPP), which plan was approved

by the annual general meeting on 15 May 2020.

53 employees participated in the 2020 ESPP in this cycle. The participating

employees have elected to invest a part of the base salary in ordinary shares in

the company. Purchase takes place every three months. The shares are restricted

for three months.

Following the issue, the Company's share capital will be NOK 137,926,078.20

divided into 919,507,188 shares each with a nominal value of NOK 0.15.

Primary insiders

IDEX discloses transactions by the following primary insiders in IDEX shares

ISIN NO0003070609:

-   CEO Vince Graziani acquired 20,490 ordinary shares at NOK 2.10 per share.

-   CTO Anthony Eaton acquired 8,029 ordinary shares at NOK 2.10 per share.

IDEX 2020 ESPP

The 2020 ESPP was approved at the annual general meeting on 15 May 2020.

Reference is made to the notice of said meeting where the plan document in

connection with the 2020 ESPP is attached.

All employees in the Company and its subsidiaries, except in China, have been

offered to subscribe for shares in the Company in connection with the ESPP. The

2020 ESPP is structured around four contribution periods a year, each starting

on the first day of the calendar month following each planned disclosure of an

interim report of the Company and lasts for the following three months. During

each contribution period, a fixed amount (up to 20% of the employee's gross base

salary) is withheld from the employee's net salary. The employee may sign up to

participate in the ESPP from the date of a public disclosure of an interim

report until the beginning of the contribution period. Unless the employee

actively withdraws from the ESPP, participation is automatically renewed for the

same amount for subsequent contribution periods. The board's resolution to issue

new shares in connection with the ESPP is made pursuant to the authorization

granted by the Company's annual general meeting on 15 May 2020 to increase the

Company's share capital in connection with the ESPP. The 2020 ESPP is now closed

for further contributions and purchases.

In accordance with the ESPP, the subscription price is the lower closing price

of the Company's share, as traded on Oslo Børs, on the first or last day of the

contribution period, less 15% discount. Payment of the subscription amount is

made out of the relevant employee salary withholding.

In accordance with Regulation (EU) 2017/1129 (the "Prospectus Regulation")

Article 1 (5) h, issuance of shares in connection with the ESPP is exempt from

the obligation to publish a listing prospectus.

For further information contact:

Marianne Bøe, Investor Relations

E-mail: [email protected]

Tel: + 47 918 00186

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of

fingerprint identification technologies offering simple, secure, and personal

touch-free authentication for all. We help people make payments, prove their

identity, gain access to information, unlock devices, or gain admittance to

buildings. We invent, engineer, and commercialize these secure and safe yet

incredibly user-friendly solutions. Our total addressable market represents a

fast growing multi-billion-unit opportunity.

For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics

This information is subject to the disclosure requirements pursuant to Section

5-12 the Norwegian Securities Trading Act